AbTx

AbTx is a biotech firm developing next-generation antibody-drug conjugates with enzymatic precision for oncology.

Health and bio

AbTx raised $1.7M in a Seed round announced September 17, 2026, according to ventureburn.com. Investors in that round: Agence Economique Regionale De Bourgogne-franche-comte, Bpifrance Digital Venture, Calyseed, Capital Cell, Covalab, DECA-BFC, Dijon métropole, Genopole, PMT - Microtechnology Hub, Santenov Dijon Bourgogne.

Raise history

1. September 17, 2026
   Seed · $1.7M
   AAgence Economique Regionale De Bourgogne-franche-comte, BBpifrance Digital Venture, CCalyseed, CCapital Cell, CCovalab, DDECA-BFC, DDijon métropole, GGenopole, PPMT - Microtechnology Hub, SSantenov Dijon Bourgogne
   Source: ventureburn.com

Investors

• AAgence Economique Regionale De Bourgogne-franche-comte
• BBpifrance Digital Venture
• CCalyseed
• CCapital Cell
• CCovalab
• DDECA-BFC
• DDijon métropole
• GGenopole
• PPMT - Microtechnology Hub
• SSantenov Dijon Bourgogne

Related bio health companies

• SSharp$328K · Oct 1, 2026
• MM-BasedOct 1, 2026
• AAyna HealthOct 1, 2026
• VVytalYou$830K · Sep 30, 2026
• LLindera USSep 29, 2026
• OOrtet$500M · Sep 29, 2026
• AAptadir Therapeutics$45M · Sep 29, 2026
• GGoerSep 29, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/abtx.